Peritoneal Membrane Failure in Peritoneal Dialysis Patients

A review is given of the conditions associated with peritoneal membrane failure, and the possible causes. Ultrafiltration failure is the most important manifestation. It is mostly associated with high transport rates of low molecular weight solutes suggesting the presence of a large vascular surface area. Enlargement of the peritoneal surface area can be functional (effective surface area: more perfused microvessels) or anatomic (more microvessels). The former is likely to be present in some patients in the beginning of peritoneal dialysis, and also during peritonitis. The latter can develop in long-term peritoneal dialysis.

[1]  B. Grabensee,et al.  Peritoneal fluid and solute transport: influence of treatment time, peritoneal dialysis modality, and peritonitis incidence. , 2002, Journal of the American Society of Nephrology : JASN.

[2]  Geraint T. Williams,et al.  Morphologic changes in the peritoneal membrane of patients with renal disease. , 2002, Journal of the American Society of Nephrology : JASN.

[3]  R. Krediet.  Dialysate Cancer Antigen 125 Concentration as Marker of Peritoneal Membrane Status in Patients Treated with Chronic Peritoneal Dialysis , 2001, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[4]  D. Zemel,et al.  Prostaglandin inhibition by intraperitoneal indomethacin has no effect on peritoneal permeability during stable CAPD. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  A. Cheung,et al.  Effect of indomethacin on peritoneal protein loss in a rabbit model of peritonitis. , 2001, Kidney international.

[6]  S. Mujais,et al.  Encapsulating Peritoneal Sclerosis: Definition, Etiology, Diagnosis, and Treatment , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[7]  Bengt Rippe,et al.  Evaluation and Management of Ultrafiltration Problems in Peritoneal Dialysis , 2000 .

[8]  B. Lindholm,et al.  Peritoneal Transport Characteristics, Comorbid Diseases and Survival in CAPD Patients , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[9]  B. Lindholm,et al.  Pathophysiology of Peritoneal Membrane Failure , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[10]  T. Chan,et al.  Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  A. C. van der Wal,et al.  Vascular and Interstitial Changes in the Peritoneum of Capd Patients with Peritoneal Sclerosis , 1999, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[12]  J. Balligand,et al.  Regulation of aquaporin-1 and nitric oxide synthase isoforms in a rat model of acute peritonitis. , 1999, Journal of the American Society of Nephrology : JASN.

[13]  F. Jamar,et al.  Expression of aquaporin-1 in a long-term peritoneal dialysis patient with impaired transcellular water transport. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  D. Struijk,et al.  Are phospholipase A2 and nitric oxide involved in the alterations in peritoneal transport during CAPD peritonitis? , 1998, The Journal of laboratory and clinical medicine.

[15]  A. Donker,et al.  Icodextrin use in CCPD patients during peritonitis: ultrafiltration and serum disaccharide concentrations. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  D. Churchill,et al.  Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. , 1998, Journal of the American Society of Nephrology : JASN.

[17]  J. Waniewski,et al.  Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  D. Oreopoulos,et al.  The Effect of a Nitric Oxide Inhibitor (L-Name) on Peritoneal Transport during Dialysis in Rats , 1998, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[19]  C. Hawley,et al.  Sclerosing peritonitis: the experience in Australia. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  Y. Kawaguchi,et al.  Issues affecting the longevity of the continuous peritoneal dialysis therapy. , 1997, Kidney international. Supplement.

[21]  D. Struijk,et al.  Longitudinal follow-up of CA125 in peritoneal effluent. , 1997, Kidney international.

[22]  B. Atasever,et al.  Analysis of Ultrafiltration Failure in Peritoneal Dialysis Patients by Means of Standard Peritoneal Permeability Analysis , 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[23]  D. Struijk,et al.  Restriction coefficients of low molecular weight solutes and macromolecules during peritoneal dialysis. , 1997, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[24]  C. Visser,et al.  Identification of the major chemokines that regulate cell influxes in peritoneal dialysis patients. , 1996, Journal of the American Society of Nephrology : JASN.

[25]  N. Schouten,et al.  Peritoneal transport characteristics with glucose polymer based dialysate. , 1996, Kidney international.

[26]  D. Struijk,et al.  Effect of electric charge on the transperitoneal transport of plasma proteins during CAPD. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[27]  S. Davies,et al.  Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[28]  D. Zemel,et al.  Impaired Initial Cell Reaction in CAPD-Related Peritonitis , 1996 .

[29]  D. Zemel,et al.  Impaired Initial Cell Reaction in Capd-Related Peritonitis , 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[30]  K. Nitta,et al.  Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. , 1996, Nephron.

[31]  D. Struijk,et al.  Dialysate CA125 in stable CAPD patients: no relation with transport parameters. , 1995, Clinical Nephrology.

[32]  M. Langedijk,et al.  The standard peritoneal permeability analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients. , 1995, Kidney international.

[33]  D. Zemel,et al.  Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis. , 1995, The Journal of laboratory and clinical medicine.

[34]  R. Gokal,et al.  Peritonitis Occurrence in a Multicenter Study of Icodextrin and Glucose in Capd , 1995 .

[35]  R. Gokal,et al.  Peritonitis Occurrence in a Multicenter Study of Icodextrin and Glucose in CAPD , 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[36]  D. Struijk,et al.  Does Impaired Transcellular Water Transport Contribute to Net Ultrafiltration Failure during CAPD? , 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[37]  D. Zemel,et al.  Nitrate in stable CAPD patients and during peritonitis. , 1995, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[38]  D. Zemel,et al.  Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPD. , 1994, Kidney international.

[39]  D. Zemel,et al.  Impact of Surface Area and Permeability on Solute Clearances , 1994, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[40]  D. Zemel,et al.  Interleukin-8 during peritonitis in patients treated with CAPD; an in-vivo model of acute inflammation. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[41]  G. Da Rin,et al.  Comparison of fast peritoneal equilibration tests with 1.36 and 3.86% dialysis solutions. , 1994, Blood purification.

[42]  R. Selgas,et al.  Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[43]  A. Brendolan,et al.  Changes in the peritoneal equilibration test in selected chronic peritoneal dialysis patients. , 1994, Journal of the American Society of Nephrology : JASN.

[44]  I. T. Ten Berge,et al.  Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. , 1993, The Journal of laboratory and clinical medicine.

[45]  D. Struijk,et al.  Effect of dialysate osmolarity on the transport of low-molecular weight solutes and proteins during CAPD. , 1993, Kidney international.

[46]  J. Dobbie.  Pathogenesis of Peritoneal Fibrosing Syndromes (Sclerosing Peritonitis) in Peritoneal Dialysis , 1992, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[47]  F. Hoek,et al.  Functional characteristics of the peritoneal membrane in long-term continuous ambulatory peritoneal dialysis. , 1991, Nephron.

[48]  J. Waniewski,et al.  Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. , 1990, Kidney international.

[49]  F. Hoek,et al.  The peritoneal transport of serum proteins and neutral dextran in CAPD patients. , 1989, Kidney international.

[50]  R. Krediet,et al.  Alterations in the peritoneal transport of water and solutes during peritonitis in continuous ambulatory peritoneal dialysis patients , 1987, European journal of clinical investigation.

[51]  R. Krediet,et al.  Peritoneal Transport Characteristics of Water, Low-Molecular Weight Solutes and Proteins during Long Term Continuous Ambulatory Peritoneal Dialysis , 1986 .

[52]  P. Schollmeyer,et al.  Prostaglandin-mediated loss of proteins during peritonitis in continuous ambulatory peritoneal dialysis. , 1986, Kidney international.

[53]  R. Krediet,et al.  Peritoneal permeability to proteins in diabetic and non-diabetic continuous ambulatory peritoneal dialysis patients. , 1986, Nephron.